Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally

Eli Lilly & Co. stock has traded above $1,000 per share over the past four years, driven partly by demand for its weight-loss medications. Some analysts have suggested the company may be a candidate for a stock split.

Next story